New Findings Regarding the Effects of Selected Blue Food Colorants (Genipin, Patent Blue V, and Brilliant Blue FCF) on the Hemostatic Properties of Blood Components In Vitro

• Published in: Nutrients Vol. 16; no. 13; p. 1985
• Main Authors: Olas, Beata, Kontek, Bogdan, Sławińska, Natalia, Białecki, Jacek
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 21-06-2024
• Subjects: Aspirin; Benzenesulfonates - pharmacology; Blood Coagulation - drug effects; blood platelet; Blood platelets; Blood Platelets - drug effects; Blood Platelets - metabolism; blue colorant; brilliant blue FCF; Collagen; Cytotoxicity; Disease prevention; Drug dosages; FDA approval; Fibrinogen - metabolism; Food Coloring Agents - pharmacology; Food products; genipin; hemostasis; Hemostasis - drug effects; Hemostatics - pharmacology; Humans; Iridoids - pharmacology; Partial Thromboplastin Time; patent blue V; Plasma; Platelet Activation - drug effects; Platelet Adhesiveness - drug effects; Prothrombin Time; Reagents; Rosaniline Dyes - pharmacology; Thrombin Time; Poland; United States > US; patent blue V; brilliant blue FCF; blood platelet; hemostasis; blue colorant; genipin
• ISSN: 2072-6643; 2072-6643
• DOI: 10.3390/nu16131985

Natural and synthetic colorants present in food can modulate hemostasis, which includes the coagulation process and blood platelet activation. Some colorants have cardioprotective activity as well. However, the effect of genipin (a natural blue colorant) and synthetic blue colorants (including patent blue V and brilliant blue FCF) on hemostasis is not clear. In this study, we aimed to investigate the effects of three blue colorants-genipin, patent blue V, and brilliant blue FCF-on selected parameters of hemostasis in vitro. The anti- or pro-coagulant potential was assessed in human plasma by measuring the following coagulation times: thrombin time (TT), prothrombin time (PT), and activated partial thromboplastin time (APTT). Moreover, we used the Total Thrombus formation Analysis System (T-TAS, PL-chip) to evaluate the anti-platelet potential of the colorants in whole blood. We also measured their effect on the adhesion of washed blood platelets to fibrinogen and collagen. Lastly, the cytotoxicity of the colorants against blood platelets was assessed based on the activity of extracellular lactate dehydrogenase (LDH). We observed that genipin (at all concentrations (1-200 µM)) did not have a significant effect on the coagulation times (PT, APTT, and TT). However, genipin at the highest concentration (200 µM) and patent blue V at the concentrations of 1 and 10 µM significantly prolonged the time of occlusion measured using the T-TAS, which demonstrated their anti-platelet activity. We also observed that genipin decreased the adhesion of platelets to fibrinogen and collagen. Only patent blue V and brilliant blue FCF significantly shortened the APTT (at the concentration of 10 µM) and TT (at concentrations of 1 and 10 µM), demonstrating pro-coagulant activity. These synthetic blue colorants also modulated the process of human blood platelet adhesion, stimulating the adhesion to fibrinogen and inhibiting the adhesion to collagen. The results demonstrate that genipin is not toxic. In addition, because of its ability to reduce blood platelet activation, genipin holds promise as a novel and valuable agent that improves the health of the cardiovascular system and reduces the risk of cardiovascular diseases. However, the mechanism of its anti-platelet activity remains unclear and requires further studies. Its in vivo activity and interaction with various anti-coagulant and anti-thrombotic drugs, including aspirin and its derivatives, should be examined as well.